November 29, 2016 - By Richard Conner · 0 Comments
The stock of CELYAD SA ORD BELGIUM (OTCMKTS:CLYYF) registered an increase of 13.53% in short interest. CLYYF’s total short interest was 23,500 shares in November as published by FINRA. Its up 13.53% from 20,700 shares, reported previously. The stock last traded at $22 per share. It is down 6.00% since October 30, 2016 and is uptrending. It has outperformed by 0.74% the S&P500.
More recent CELYAD NPV (OTCMKTS:CLYYF) news were published by: Seekingalpha.com which released: “Celyad: An Unknown Biotech That Will Fix Your Broken Heart” on January 23, 2016. Also Seekingalpha.com published the news titled: “Celyad (CYAD) CEO Christian Homsy on Q4 2015 Results – Earnings Call Transcript” on March 24, 2016. Seekingalpha.com‘s news article titled: “Why Juno Therapeutics Could Be The Future Leader In CAR-T And TCR Immune …” with publication date: September 12, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Richard Conner